Search

The study, done on a mild-mannered relative of the virus that causes COVID-19, paves the way for seeing more clearly how spike proteins initiate infections, with an eye to preventing and treating them.

Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature.

The lab is responding to the coronavirus crisis by imaging disease-related biomolecules, developing standards for reliable coronavirus testing and enabling other essential research.

Scientists are deploying this state-of-the-art X-ray crystallography facility to study biological molecules related to the COVID-19 pandemic.

University of Alberta researchers worked with SLAC X-ray scientists to explore the potential of a feline coronavirus drug that may be effective against SARS-CoV-2.

They found that gently heating N95 masks in high relative humidity could inactivate SARS-CoV-2 virus trapped within the masks, without degrading the masks’ performance.

No human cell can function without these tiny machines, which cause disease when they go haywire and offer potential targets for therapeutic drugs.

The center complements other NIH centers at SLAC and elsewhere that broaden access to this cutting-edge technology for biomedical research.

Sandwiching wiggly proteins between two other layers allows scientists to get the most detailed images yet of a protein that’s key to the spread of acute myeloid leukemia.

By revealing the chemistry of plant secretions, or exudates, these studies build a basis for better understanding and conserving art and tools made with plant materials.

Researchers found a protein that's essential for an enterovirus to enter human cells. That could help the search for vaccines and treatments. 

Cryogenic electron microscopy showed for the first time that large RNA complexes can assemble without the help of proteins.